Identification of Δ-1-pyrroline-5-carboxylate derived biomarkers for hyperprolinemia type II
Combined metabolomics, NMR, and, IRIS identify biomarkers of hyperprolinemia type II (HPII) distinct from HPI and similar metabolic signatures as in patients with pyridoxine-dependent epilepsy.
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-09-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-022-03960-2 |